SAN ANTONIO – Five years of tamoxifen provided 20 years of breast cancer prevention to some at-risk women who took it prophylactically.
However, their 20-year all-cause mortality was no different...
SAN ANTONIO – Our reporter Michele Sullivan asked selected attendees at the San Antonio Breast Cancer Symposium to identify the most interesting or practice-changing study presented at the meeting....
CHICAGO– The “timing hypothesis” of estrogen’s ability to slow progression of atherosclerotic disease in relatively young postmenopausal women received a boost in results from a randomized trial with...
SAN ANTONIO – Roughly one in five women with heavily pretreated, advanced triple-negative breast cancer experienced a durable response to monotherapy using the novel immune checkpoint inhibitor...
Even as the number of women aged 50 years and older continues to rise, the percentage who are taking osteoporosis medications has fallen by one-third since 2004-2005, the Agency for Healthcare...
Supplemental screening ultrasonography would add substantial costs while providing little clinical benefit after a negative screening mammography in women with dense breasts, according to three...
PHILADELPHIA – Renal biopsies are a useful tool for optimizing outcomes in pregnant patients with active lupus nephritis, according to Dr. Derek M. Fine.
Although caution is advisable, a general...
Long-acting reversible contraception can lead to significantly decreased rates of pregnancy, abortion, and births among teenagers in the United States, according to a web presentation given by the...
SCOTTSDALE, ARIZ. – Experts have not reached consensus on prescribing oral contraceptives for women with migraine, revealing the need for better studies of stroke risk in these patients, said Dr....
SCOTTSDALE, ARIZ. - The first randomized, controlled trial of behavioral weight loss as a treatment for migraine in women is underway, with results expected in mid-2016.
The trial “provides an...
